Migraine Clinical Trials
2 recruiting trials for Migraine. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Migraine clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 4 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Ain Shams University (1), Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Caffeine (200 mg) (drug, 1 trial), followed by triptans, NSAID (Nonsteroidal anti-inflammatory drugs).
Track Migraine trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients...
Caffeine extracted from green tea to abort acute attack of Migraine
Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables
The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Migraine, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Migraine, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Migraine, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.